Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOB | P27338 | 2/20 | 0.36 |
| ▸ | GAA | P10253 | 1/20 | 0.34 |
| ▸ | PRNP | P04156 | 1/20 | 0.34 |
| ▸ | MEN1 | O00255 | 2/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.32 |
| ▸ | NPC1 | O15118 | 2/20 | 0.31 |
| ▸ | RAB9A | P51151 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.31 |
| ▸ | FABP4 | P15090 | 1/20 | 0.31 |
| ▸ | CTSL | P07711 | 1/20 | 0.30 |
| ▸ | HPGD | P15428 | 1/20 | 0.30 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.30 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2360435 | 0.80 | PRNP (0.32) | MAOBGAAPRNPMEN1KMT2A | |
| SCHEMBL153460 | 0.78 | NPC1 (0.42) | MEN1KMT2ANPC1RAB9AALDH1A1 | |
| SCHEMBL8495468 | 0.77 | PRNP (0.50) | MAOBGAAPRNPMEN1KMT2A | |
| SCHEMBL16960567 | 0.77 | ALDH1A1 (0.35) | MAOBGAAPRNPMEN1KMT2A | |
| SCHEMBL156339 | 0.76 | ERN1 (0.32) | — | |
| SCHEMBL588389 | 0.75 | PRNP (0.53) | PRNPKMT2AALDH1A1FABP4HPGD | |
| SCHEMBL28482995 | 0.73 | PRNP (0.39) | MAOBGAAPRNPMEN1KMT2A | |
| SCHEMBL3170417 | 0.73 | METAP2 (0.48) | GAAALDH1A1HPGDHSD17B10 | |
| SCHEMBL9136350 | 0.73 | PRNP (0.56) | MAOBGAAPRNPMEN1KMT2A | |
| SCHEMBL28958191 | 0.73 | ALDH1A1 (0.37) | GAAPRNPMEN1KMT2ANPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240052081-A1 | PHOTO-CURABLE COMPOSITIONS CONTAINING HIGH REFRACTIVE INDEX MONOMERS FOR USE IN 3D PRINTING APPLICATIONS | ARKEMA FRANCE (FR) | 2024-02-15 | — | — | US | claimed |
| EP-4028480-A1 | PHOTO-CURABLE COMPOSITIONS CONTAINING HIGH REFRACTIVE INDEX MONOMERS FOR USE IN 3D PRINTING APPLICATIONS | ARKEMA FRANCE (FR) | 2022-07-20 | — | — | EP | claimed |
| CN-114651049-A | Photocurable compositions containing high refractive index monomers for 3D printing applications | 阿科玛法国公司 | 2022-06-21 | — | — | CN | claimed |
| WO-2021048628-A1 | PHOTO-CURABLE COMPOSITIONS CONTAINING HIGH REFRACTIVE INDEX MONOMERS FOR USE IN 3D PRINTING APPLICATIONS | ARKEMA FRANCE (FR) | 2021-03-18 | — | — | WO | claimed |
| US-20240052081-A1 | PHOTO-CURABLE COMPOSITIONS CONTAINING HIGH REFRACTIVE INDEX MONOMERS FOR USE IN 3D PRINTING APPLICATIONS | ARKEMA FRANCE (FR) | 2024-02-15 | — | — | US | disclosed |
| EP-4028480-A1 | PHOTO-CURABLE COMPOSITIONS CONTAINING HIGH REFRACTIVE INDEX MONOMERS FOR USE IN 3D PRINTING APPLICATIONS | ARKEMA FRANCE (FR) | 2022-07-20 | — | — | EP | disclosed |
| CN-114651049-A | Photocurable compositions containing high refractive index monomers for 3D printing applications | 阿科玛法国公司 | 2022-06-21 | — | — | CN | disclosed |
| WO-2021048628-A1 | PHOTO-CURABLE COMPOSITIONS CONTAINING HIGH REFRACTIVE INDEX MONOMERS FOR USE IN 3D PRINTING APPLICATIONS | ARKEMA FRANCE (FR) | 2021-03-18 | — | — | WO | disclosed |
| EP-2944673-A1 | POLYBUTYLENE TEREPHTHALATE RESIN COMPOSITION, AND MOLDED ARTICLE | Mitsubishi Engineering-Plastics Corporation (JP) | 2015-11-18 | — | — | EP | disclosed |
| WO-2008073534-A1 | METAL OXIDE AND SULFUR-CONTAINING COATING COMPOSITIONS, METHODS OF USE, AND ARTICLES PREPARED THEREFROM | GENERAL ELECTRIC COMPANY (US) | 2008-06-19 | — | — | WO | disclosed |
| US-7341784-B2 | Light management film and its preparation and use | GENERAL ELECTRIC COMPANY (US) | 2008-03-11 | — | — | US | disclosed |
| US-7271283-B2 | High refractive index, UV-curable monomers and coating compositions prepared therefrom | GENERAL ELECTRIC COMPANY (US) | 2007-09-18 | — | — | US | disclosed |
| EP-1631603-A1 | CURABLE (METH)ACRYLATE COMPOSITIONS | GENERAL ELECTRIC COMPANY (US) | 2006-03-08 | — | — | EP | disclosed |
| EP-1512704-A1 | High refractive index, UV-curable monomers and coating compositions prepared therefrom | GENERAL ELECTRIC COMPANY (US) | 2005-03-09 | — | — | EP | disclosed |
| US-20050049376-A1 | High refractive index, uv-curable monomers and coating compositions prepared therefrom | GENERAL ELECTRIC COMPANY | 2005-03-03 | — | — | US | disclosed |
| US-6833391-B1 | Comprising three monomers having highly brominated phenyl, arylether and bisphenol A or F functionality and initiator; light management films; high refractive index; brightness | GENERAL ELECTRIC COMPANY | 2004-12-21 | — | — | US | disclosed |
| WO-2004106396-A1 | CURABLE (METH)ACRYLATE COMPOSITIONS | GENERAL ELECTRIC COMPANY (US) | 2004-12-09 | — | — | WO | disclosed |
| US-20040249100-A1 | CURABLE (METH)ACRYLATE COMPOSITIONS | GENERAL ELECTRIC COMPANY (US) | 2004-12-09 | — | — | US | disclosed |
| US-20040242720-A1 | Curable (meth)acrylate compositions | CITIBANK, N.A., AS COLLATERAL AGENT | 2004-12-02 | — | — | US | disclosed |
| US-4301088-A | Method of preparing benzyl alcohols by decarbonylation of formic acid esters | DYNAMIT NOBEL AG (DE) | 1981-11-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050049376-A1 | High refractive index, uv-curable monomers and coating compositions prepared therefrom | MACF1, WASF2, THEM6 | MAOB 4170/4885GAA 3042/4885PRNP 1417/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.